357 related articles for article (PubMed ID: 12374571)
1. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
[TBL] [Abstract][Full Text] [Related]
2. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
[TBL] [Abstract][Full Text] [Related]
4. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
[TBL] [Abstract][Full Text] [Related]
5. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
[TBL] [Abstract][Full Text] [Related]
6. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.
Hersberger M; Innerarity TL
J Biol Chem; 1998 Apr; 273(16):9435-42. PubMed ID: 9545269
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
[TBL] [Abstract][Full Text] [Related]
8. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
[TBL] [Abstract][Full Text] [Related]
9. Curcumin regulates the metabolism of low density lipoproteins by improving the C-to-U RNA editing efficiency of apolipoprotein B in primary rat hepatocytes.
Tian N; Li X; Luo Y; Han Z; Li Z; Fan C
Mol Med Rep; 2014 Jan; 9(1):132-6. PubMed ID: 24173373
[TBL] [Abstract][Full Text] [Related]
10. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
[TBL] [Abstract][Full Text] [Related]
11. Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.
Siddiqui JF; Van Mater D; Sowden MP; Smith HC
Exp Cell Res; 1999 Oct; 252(1):154-64. PubMed ID: 10502408
[TBL] [Abstract][Full Text] [Related]
12. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
Davidson NO; Shelness GS
Annu Rev Nutr; 2000; 20():169-93. PubMed ID: 10940331
[TBL] [Abstract][Full Text] [Related]
13. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
Greeve J; Axelos D; Welker S; Schipper M; Greten H
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
Sowden MP; Eagleton MJ; Smith HC
Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein B: from editosome to proteasome.
Chan L; Chang BH; Liao W; Oka K; Lau PP
Recent Prog Horm Res; 2000; 55():93-125; discussion 126. PubMed ID: 11036935
[TBL] [Abstract][Full Text] [Related]
16. Recapture of hepatic apolipoprotein B mRNA editing may be a promising strategy to relieve nephrotic dyslipidemia.
Hu P; Lu L; Hu B; Qin YH
Med Hypotheses; 2010 Dec; 75(6):561-3. PubMed ID: 20705399
[TBL] [Abstract][Full Text] [Related]
17. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
[TBL] [Abstract][Full Text] [Related]
18. Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.
Lau PP; Chan L
J Biol Chem; 2003 Dec; 278(52):52988-96. PubMed ID: 14559896
[TBL] [Abstract][Full Text] [Related]
19. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits.
Kozarsky KF; Bonen DK; Giannoni F; Funahashi T; Wilson JM; Davidson NO
Hum Gene Ther; 1996 May; 7(8):943-57. PubMed ID: 8727508
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism.
Mukhopadhyay D; Plateroti M; Anant S; Nassir F; Samarut J; Davidson NO
Endocrinology; 2003 Feb; 144(2):711-9. PubMed ID: 12538634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]